Challenges with the differential diagnosis of progressive supranuclear palsy and Parkinson’s disease

Cover Page

Abstract

Progressive supranuclear palsy (PSP) is a severe old-age neurodegenerative disease that is characterized by pronounced clinical polymorphism and has different phenotypes. Practical differential diagnosis of PSP and Parkinson’s disease (PD) presents significant challenge, especially in onset of the disease. We report an atypical case of PSP characterized by symmetric levodopa-resistant parkinsonian syndrome, early postural instability, supranuclear oculomotor disorders (vertical gaze palsy), MR signs of midbrain atrophy, and a number of overlapping clinical symptoms similar with the manifestations of PD. A detailed algorithm of differential diagnosis of PSP and PD as well as a more adequate diagnostic formulation are proposed for this and similar cases of neurodegenerative pathology.

About the authors

R. V. Magzhanov

Bashkir State Medical University

Author for correspondence.
Email: platonova@neurology.ru
Russian Federation

A. I. Davletova

Bashkir State Medical University

Email: platonova@neurology.ru
Russian Federation

R. А. Ibatullin

Kuvatov Republican Clinical Hospital (Ufa)

Email: platonova@neurology.ru
Russian Federation

V. F. Tunik

Kuvatov Republican Clinical Hospital (Ufa)

Email: platonova@neurology.ru
Russian Federation

R. F. Idrisova

Kuvatov Republican Clinical Hospital (Ufa)

Email: platonova@neurology.ru
Russian Federation

K. Z. Bakhtiyarova

Kuvatov Republican Clinical Hospital (Ufa)

Email: platonova@neurology.ru
Russian Federation

References

  1. Ivanova-Smolenskaja I.A., Markova E.D., Illarioshkin S.N., Nikol’skaja N.N. [Monogenic hereditary diseases of the central nervous system] In.: Ju.E. Vel’tishheva, P.A. Temina (eds.) Nasledstvennye bolezni nervnoj sistemy [Hereditary diseases of the nervous system]. Moscow. Medicina Publ., 1998: 9–104. (In Russ.).
  2. Periquet M., Lucking C., Vaughan J. et al. Origin of the mutations in the PARKIN gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from founder effects. Am. J. Hum. Genet. 2001; 68: 617–26. doi: 10.1086/318791. PMID: 11179010.
  3. Illarioshkin S.N. DNK-diagnostika i mediko-geneticheskoe konsul’tirovanie [DNA-diagnostics and medical-genetic counseling]. Moscow. MIA Publ., 2004. (in Russ.).
  4. Artem’ev D.V., Golubev V.L., Jahno N.N. [Progressive supranuclear palsy]. In.: N.N. Jahno (ed.) Bolezni nervnoj sistemy [Diseases of the nervous system], V. 2. Moscow. Medicina Publ., 2007: 96–100. (in Russ.).
  5. Shtok V.N., Levin O.S., Fedorova N.V. Ekstrapiramidnyye rasstroystva [Extrapyramidal disorders]. Moscow. MIA Publ., 2002. (in Russ.).
  6. Colosimo C., Riley D.E., Wenning G.K. Handbook of atypical parkinsonism. NY: Cambridge University Press, 2011. doi: 10.1017/CBO9780511920936.
  7. Dickson D.W., Rademakers R., Hutton M.L. Progressive supranuclear palsy: pathology and genetics. Brain Pathol. 2007; 17: 74–82. doi: 10.1111/j.1750-3639.2007.00054.x. PMID: 17493041.
  8. Wakabayashi K., Takahashi H. Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 2004; 24: 79–86. doi: 10.1111/j.1440-1789.2003.00543.x. PMID: 15068177.
  9. Ludolph A.C., Kassubek J., Landwehrmeyer B.G. et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers and treatment options. Eur. J. Neurol. 2009; 16: 297–309. doi: 10.1111/j.1468-1331.2008.02513.x. PMID: 19364361.
  10. Williams D.R., Lees A.J. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009;
  11. : 270–279. doi: 10.1016/S1474-4422(09)70042-0. PMID: 19233037.
  12. Litvan I., Agid Y., Calne D. et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1–9. PMID: 8710059.
  13. Levin O.S., Fedorova N.V. Bolezn’ Parkinsona [Parkinson’s disease]. Moscow.: MEDpress-inform Publ., 2014. (in Russ.).
  14. Williams D.R., Lees A.J. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)? Mov. Disord. 2010; 25: 357–362. doi: 10.1002/mds.22977. PMID: 20108379.
  15. Lopez G., Bayulkem K., Hallett M. Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants. ActaNeuro. l Scand. 2016; 134: 242–249. doi: 10.1111/ane.12546. PMID: 27070344.
  16. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry. 1988; 51: 745–752. doi: 10.1136/jnnp.51.6.745. PMID: 2841426.
  17. Fedotova E.Ju., Chechetkin A.O., Ivanova-Smolenskaja I.A., Illarioshkin S.N. [The case of progressive supranuclear palsy with corticobasal syndrome]. Nervnye bolezni. 2009; 2: 38–43. (in Russ.).

Statistics

Views

Abstract: 1134

PDF (Russian): 951

Article Metrics

Metrics Loading ...

Dimensions

PlumX


Copyright (c) 2017 Magzhanov R.V., Davletova A.I., Ibatullin R.А., Tunik V.F., Idrisova R.F., Bakhtiyarova K.Z.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies